BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4653589)

  • 1. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.
    Robertson WG; Peacock M
    Clin Sci; 1972 Oct; 43(4):499-506. PubMed ID: 4653589
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium crystalluria in recurrent renal-stone formers.
    Robertson WG; Peacock M; Nordin BE
    Lancet; 1969 Jul; 2(7610):21-4. PubMed ID: 4182793
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 4. Determinants of supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers: effects of nondialyzable materials.
    Gill WB; Roma MJ
    J Surg Res; 1976 Jul; 21(1):45-9. PubMed ID: 933515
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.
    Hallson PC; Rose GA
    Br J Urol; 1976; 48(7):515-24. PubMed ID: 13904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine oxalate and calcium in idiopathic renal stone formers.
    Wallace MR; Mason K; Gray J
    N Z Med J; 1981 Aug; 94(689):87-9. PubMed ID: 6944647
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the risk of stone formation: study on crystalluria in patients with recurrent calcium oxalate urolithiasis.
    Robert M; Boularan AM; Delbos O; Monnier L; Grasset D
    Eur Urol; 1996; 29(4):456-61. PubMed ID: 8791054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of urinary calcium and oxalate on three diets in patients with urolithiasis.
    Juuti M; Alhava EM
    Ann Clin Res; 1980 Dec; 12(6):320-5. PubMed ID: 7235608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.
    Robertson WG; Peacock M; Marshall RW; Knowles F
    Clin Sci Mol Med; 1974 Jul; 47(1):13-22. PubMed ID: 4277691
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of crystalluria in renal stone formation.
    Robertson WG; Peacock M; Nordin BE
    Br J Surg; 1969 May; 56(5):388-9. PubMed ID: 5781083
    [No Abstract]   [Full Text] [Related]  

  • 18. Urine oxalate levels in a New Zealand reference population and renal stone formers.
    Larking P; Lovell-Smith CJ; Hocken AG
    N Z Med J; 1983 Aug; 96(737):606-7. PubMed ID: 6575312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to renal stone disease in the first-degree relatives of stone-formers.
    Marya RK; Dadoo RC; Sharma NK
    Urol Int; 1981; 36(4):245-7. PubMed ID: 7331055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.